Jenburkt Pharmaceuticals’ premium consumer-wellness division launches ‘Zixa Strong’

04 Apr 2022 Evaluate

Jenburkt Wellness, the premium consumer-wellness division from the house of publicly listed organization Jenburkt Pharmaceuticals, has launched Zixa Strong, a high-performing pain-relief range that delivers fast-acting and long-lasting relief from muscle and joint pains. Created using an innovative, scientifically advanced oil-in-water FlashMicelle technology, Zixa Strong promises to create a revolution in the pain relief category with its non-greasy, quick-absorption mechanism and unique formula for immediate pain relief.

Zixa Strong - a topical analgesic - has been developed at Jenburkt’s R & D Centre by a team of experienced professionals. It is targeted at the rapidly growing healthy and fit population of India. The product range is recommended for fast-acting, long-lasting relief from back pain, rheumatic pain, muscular aches, pains and swellings such as strains, sprains and sport injuries. It is also suitable for the relief from pain associated with non-serious arthritic conditions.

Jenburkt Pharmaceuticals is a deeply-trusted public-listed pharmaceutical organisation headquartered in Mumbai, India with a presence spanning 13 countries.

Jenburkt Pharma Share Price

783.00 -8.80 (-1.11%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.